Skip to main content

Child and Adolescent Major Depressive Disorder: Diagnostic Evaluation

CBE ID
1364
1.4 Project
Behavioral Health
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2016
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 6 through 17 years with a diagnosis of major depressive disorder with documented evidence that they met the DSM-IV criteria [at least 5 elements with symptom duration of two weeks or longer, including 1) depressed mood (can be irritable mood in children and adolescents) or 2) loss of interest or pleasure] during the visit in which the new diagnosis or recurrent episode was identified

    • 1.14 Numerator

      Patients with documented evidence that they met the DSM-IV criteria [at least 5 elements with symptom duration of two weeks or longer, including 1) depressed mood (can be irritable mood in children and adolescents) or 2) loss of interest or pleasure] during the visit in which the new diagnosis or recurrent episode was identified

    • 1.15 Denominator

      All patients aged 6 through 17 years with a diagnosis of major depressive disorder

    • Exclusions

      None

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Behavioral Health Project 2016-2017
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      Physician Consortium for Performance Improvement
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      Physician Performance Measures (Measures) and related data specifications are developed by the American Medical Association (AMA) in collaboration with the Physician Consortium for Performance Improvement® (PCPI).

      These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.

      The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI). Neither the AMA, the PCPI nor its members shall be responsible for any use of the Measures.

      THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.

      © 2008 American Medical Association. All Rights Reserved.

      Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, NCQA, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.

      CPT® contained in the Measures specifications is copyright 2007 American Medical Association. LOINC® copyright 2004 Regenstrief Institute, Inc. SNOMED CLINICAL TERMS (SNOMED CT®) copyright 2004 College of American Pathologists (CAP). All Rights Reserved. Use of SNOMED CT® is only authorized within the United States.